PortfoliosLab logoPortfoliosLab logo
Tekla Healthcare Investors (HQH)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US87911J1034
CUSIP
87911J103
IPO Date
Jan 5, 1988

Highlights

Total Revenue (TTM)
$21.06M
Gross Profit (TTM)
$21.06M
Year Range
$13.77 - $20.46

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Tekla Healthcare Investors, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Tekla Healthcare Investors (HQH) has returned -3.09% so far this year and 24.44% over the past 12 months. Over the last ten years, HQH has returned 6.57% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Tekla Healthcare Investors

1D
3.13%
1M
-7.10%
YTD
-3.09%
6M
2.57%
1Y
24.44%
3Y*
13.07%
5Y*
4.30%
10Y*
6.57%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jan 5, 1988, HQH's average daily return is +0.05%, while the average monthly return is +1.09%. At this rate, your investment would double in approximately 5.3 years.

Historically, 56% of months were positive and 44% were negative. The best month was Feb 2000 with a return of +60.4%, while the worst month was Mar 2000 at -30.5%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 5 months.

On a daily basis, HQH closed higher 48% of trading days. The best single day was Feb 17, 2000 with a return of +13.3%, while the worst single day was Nov 14, 1996 at -22.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20260.84%3.45%-7.10%-3.09%
202513.15%-2.23%-5.58%0.00%-3.02%1.77%1.03%9.00%11.61%6.66%2.32%-3.02%34.12%
20243.38%0.97%0.24%-4.21%6.15%5.43%6.36%5.27%-1.74%-3.17%0.18%-7.92%10.22%
20235.67%-3.29%-1.84%-1.36%-1.47%1.73%0.06%-0.59%-6.10%-6.05%4.64%11.13%1.22%
2022-5.01%-9.13%3.80%-2.79%-0.86%-4.50%3.37%-1.77%-7.10%8.51%4.43%-6.15%-17.27%
20210.04%6.81%-2.20%1.84%0.67%4.93%0.89%5.00%-4.41%2.15%-5.42%-1.82%7.99%

Benchmark Metrics

Tekla Healthcare Investors has an annualized alpha of 5.01%, beta of 0.83, and R² of 0.30 versus S&P 500 Index. Calculated based on daily prices since January 06, 1988.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (97.95%) than losses (92.50%) — typical of diversified or defensive assets.
  • R² of 0.30 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
5.01%
Beta
0.83
0.30
Upside Capture
97.95%
Downside Capture
92.50%

Return for Risk

Risk / Return Rank

HQH ranks 72 for risk / return — better than 72% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


HQH Risk / Return Rank: 7272
Overall Rank
HQH Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
HQH Sortino Ratio Rank: 6767
Sortino Ratio Rank
HQH Omega Ratio Rank: 6565
Omega Ratio Rank
HQH Calmar Ratio Rank: 7373
Calmar Ratio Rank
HQH Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Tekla Healthcare Investors (HQH) and compare them to a chosen benchmark (S&P 500 Index).


HQHBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.05

0.90

+0.16

Sortino ratio

Return per unit of downside risk

1.49

1.39

+0.11

Omega ratio

Gain probability vs. loss probability

1.19

1.21

-0.02

Calmar ratio

Return relative to maximum drawdown

1.73

1.40

+0.33

Martin ratio

Return relative to average drawdown

5.46

6.61

-1.15

Explore HQH risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Tekla Healthcare Investors provided a 12.65% dividend yield over the last twelve months, with an annual payout of $2.25 per share.


8.00%9.00%10.00%11.00%12.00%13.00%14.00%$0.00$1.00$2.00$3.00$4.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$2.25$2.19$2.28$1.60$1.71$2.04$1.90$1.72$1.93$1.98$2.07$3.55

Dividend yield

12.65%11.56%14.21%9.66%9.50%8.59%7.97%8.24%10.75%8.78%9.80%11.97%

Monthly Dividends

The table displays the monthly dividend distributions for Tekla Healthcare Investors. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.63$0.00$0.63
2025$0.00$0.57$0.00$0.00$0.54$0.00$0.00$0.51$0.00$0.00$0.57$0.00$2.19
2024$0.00$0.48$0.00$0.00$0.59$0.00$0.00$0.59$0.00$0.00$0.62$0.00$2.28
2023$0.00$0.42$0.00$0.00$0.40$0.00$0.00$0.40$0.00$0.00$0.38$0.00$1.60
2022$0.00$0.48$0.00$0.00$0.44$0.00$0.00$0.40$0.00$0.00$0.39$0.00$1.71
2021$0.00$0.51$0.00$0.00$0.50$0.00$0.00$0.52$0.00$0.00$0.51$0.00$2.04

Dividend Yield & Payout


Dividend Yield

Tekla Healthcare Investors has a dividend yield of 12.65%, which means its dividend payment is significantly above the market average.

Payout Ratio

Tekla Healthcare Investors has a payout ratio of 6.95%, which is below the market average. This means Tekla Healthcare Investors returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Tekla Healthcare Investors. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Tekla Healthcare Investors was 62.36%, occurring on Oct 8, 1998. Recovery took 336 trading sessions.

The current Tekla Healthcare Investors drawdown is 10.29%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-62.36%Jan 10, 19921706Oct 8, 1998336Feb 8, 20002042
-54.64%Feb 18, 2000662Oct 9, 20021168Jun 1, 20071830
-45.27%Aug 18, 2008140Mar 9, 2009469Jan 14, 2011609
-41.83%Jul 20, 2015144Feb 11, 20161226Dec 23, 20201370
-37.55%Aug 26, 2021547Oct 27, 2023480Sep 29, 20251027

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Tekla Healthcare Investors over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Tekla Healthcare Investors is priced in the market compared to other companies in the Asset Management industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items